Literature DB >> 406603

Angiokeratoma corporis diffusum: the evolution of a disease entity.

A Taaffe.   

Abstract

The clinical features, diagnosis management, aetiology and inheritance of angiokeratoma corporis diffusum (Fabry's disease) are discussed and the literature reviewed. The treatment and knowledge generally of this rare condition have not greatly improved in 75 years.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 406603      PMCID: PMC2496609          DOI: 10.1136/pgmj.53.616.78

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  11 in total

1.  FABRY'S DISEASE: CLASSIFICATION AS A SPHINGOLIPIDOSIS AND PARTIAL CHARACTERIZATION OF A NOVEL GLYCOLIPID.

Authors:  C C SWEELEY; B KLIONSKY
Journal:  J Biol Chem       Date:  1963-09       Impact factor: 5.157

2.  THE NEUROPATHOLOGY OF HEREDITARY DYSTOPIC LIPIDOSIS.

Authors:  A N RAHMAN; R LINDENBERG
Journal:  Arch Neurol       Date:  1963-10

3.  ANGIOKERATOMA CORPORIS DIFFUSUM (FABRY'S DISEASE).

Authors:  G VONGEMMINGEN; R R KIERLAND; J M OPITZ
Journal:  Arch Dermatol       Date:  1965-03

4.  Angiokeratoma corporis diffusum. A clinical study of eight affected families.

Authors:  D WISE; H J WALLACE; E H JELLINEK
Journal:  Q J Med       Date:  1962-04

5.  Enzyme transplantation in Fabry's disease.

Authors:  W Krivit; R J Desnick; R W Bernlohr; F Wold; J S Najarian; R L Simmons
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

6.  Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease.

Authors:  R O Brady; J F Tallman; W G Johnson; A E Gal; W R Leahy; J M Quirk; A S Dekaban
Journal:  N Engl J Med       Date:  1973-07-05       Impact factor: 91.245

7.  Fabry's disease in children.

Authors:  W P De Groot
Journal:  Br J Dermatol       Date:  1970-04       Impact factor: 9.302

8.  Fabry's disease with hypogammaglobulinemia and without angiokeratomas.

Authors:  G Urbain; M Philippart; J Peremans
Journal:  Arch Intern Med       Date:  1969-07

9.  Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency.

Authors:  R O Brady; A E Gal; R M Bradley; E Martensson; A L Warshaw; L Laster
Journal:  N Engl J Med       Date:  1967-05-25       Impact factor: 91.245

10.  Fabry's disease: alpha-galactosidase deficiency.

Authors:  J A Kint
Journal:  Science       Date:  1970-02-27       Impact factor: 47.728

View more
  1 in total

1.  Fabry's disease: a family study.

Authors:  T O'Brien; M Bolster; P Sullivan
Journal:  Ir J Med Sci       Date:  1990-04       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.